Amanote Research
Register
Sign In
Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity Against Rhabdomyosarcoma With the Expression of Caspase-8 Predictive of Response
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-10-2874
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
March 8, 2011
Authors
Z. Kang
J.-J. Chen
Y. Yu
B. Li
S.-Y. Sun
B. Zhang
L. Cao
Publisher
American Association for Cancer Research (AACR)
Related search
Caspase-8 Expression Is Predictive of Tumour Response to Death Receptor 5 Agonist Antibody in Ewing’s Sarcoma
British Journal of Cancer
Cancer Research
Oncology
GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
A Neutralizing Anti-Fibroblast Growth Factor 8 Monoclonal Antibody Shows Potent Antitumor Activity Against Androgen-Dependent Mouse Mammary Tumors in Vivo
Clinical Cancer Research
Cancer Research
Oncology
PF-03732010: A Fully Human Monoclonal Antibody Against P-Cadherin With Antitumor and Antimetastatic Activity
Clinical Cancer Research
Cancer Research
Oncology
In Vitro Characterization of AA71, a Potent and Selective Human Monoclonal Antibody Against CGRP Receptor
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Antitumor Activity of 7-(Hydroxyamino)-5, 8-Quinolinedione
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Activation of P38 Mitogen-Activated Protein Kinase Is Required for Death Receptor-Independent Caspase-8 Activation and Cell Death in Response to Sphingosine
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Sorafenib Has Potent Antitumor Activity Against Multiple Myeloma in Vitro, Ex Vivo, and in Vivo in the 5T33MM Mouse Model
Cancer Research
Cancer Research
Oncology